Quality Enhancement Program (QEP™)
- Why Work With NSF?
NSF Health Sciences Pharma Biotech has developed a proprietary methodology, the Quality Enhancement Program (QEP™), to address quality system shortcomings and strengthen a company’s overall quality management system. We’ve effectively implemented the QEP approach at a number of small, mid-size and large companies.
The QEP approach is systems-based and seeks to remediate root causes by creating workable, efficient processes to ensure compliance and adherence to best practices. Sustainable and robust, the QEP has corporate-wide applicability and achieves outstanding business results in the form of reduced waste, lower costs, less rework, fewer recalls, fewer complaints and more satisfied customers. The QEP takes a process and risk-based approach to developing a “best-fit” quality management system framework in collaboration with the client. In developing the framework, the QEP allows for the examination of roles, responsibilities and processes individually and with one another, while carefully considering the company’s organizational structure, mission and underlying culture.
For more information about NSF Pharma Biotech services in quality systems and compliance in the U.S., email email@example.com or call +1 202.822.1850.
For more information about NSF Pharma Biotech services in quality systems and compliance in Europe, email firstname.lastname@example.org or call +44 1751 432 999.
Why Work With NSF?
No one else can provide the Quality Enhancement Program (QEP™)! This proprietary approach is exclusive to NSF, it is proven and it is trusted by key pharma companies around the globe.
- 4 weeks ago
ANN ARBOR, Mich., USA and York, UK – NSF International, a global public health and safety organization, today announced the...
- 3 months ago
Martin Lush, President of NSF Health Sciences Pharma Biotech, was invited by the organizers of Pharma Integrates to facilitate the...
- 4 months ago
FDA Regulatory and Compliance News FDA’s Center for Devices and Radiological Health (CDRH) announced the availability of a guidance for...
- Tuesday, February 28, 2017
- 8:30am - 1:00pm GMT
- Manchester, UK, United Kingdom
- Friday, March 3, 2017
- 1:00pm - 1:30pm GMT
- Webinar, United Kingdom
- Monday, March 6, 2017
- 8:30am - 4:30pm GMT
- York, United Kingdom
- Monday, March 13, 2017
- 8:30am - 1:00pm GMT
- Manchester, United Kingdom